China Biopharma Plastics Market Size & Outlook, 2024-2030

The biopharma plastics market in China is expected to reach a projected revenue of US$ 1,134.5 million by 2030. A compound annual growth rate of 12.2% is expected of China biopharma plastics market from 2025 to 2030.
Revenue, 2024 (US$M)
$568.7
Forecast, 2030 (US$M)
$1,134.5
CAGR, 2025 - 2030
12.2%
Report Coverage
China

China biopharma plastics market highlights

  • The China biopharma plastics market generated a revenue of USD 453.0 million in 2022 and is expected to reach USD 1,134.5 million by 2030.
  • The China market is expected to grow at a CAGR of 12.2% from 2023 to 2030.
  • In terms of segment, polyvinyl chloride (pvc) was the largest revenue generating polymer type in 2022.
  • Polyvinyl Chloride (PVC) is the most lucrative polymer type segment registering the fastest growth during the forecast period.


Biopharma plastics market data book summary

Market revenue in 2022USD 453.0 million
Market revenue in 2030USD 1,134.5 million
Growth rate12.2% (CAGR from 2022 to 2030)
Largest segmentPolyvinyl chloride (pvc)
Fastest growing segmentPolyvinyl Chloride (PVC)
Historical data2019 - 2021
Base year2022
Forecast period2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPolyethylene (PE), Polypropylene (PP), Acrylonitrile Butadiene Styrene (ABS), Polyethylene Terephthalate (PET), Polyvinyl Chloride (PVC), Polytetrafluoroethylene (PTFE), Polycarbonate (PC), Other
Key market players worldwideBasf SE, LyondellBasell Industries NV Class A, SABIC, LG Chem, Toray Industries Inc, Solvay SA, Dow Inc, DuPont de Nemours Inc, Compagnie de Saint-Gobain SA, Tekni-Plex, Chevron Corp, Exxon Mobil Corp, Covestro AG, Teijin Ltd, Mitsui Chemicals Inc, Formosa Plastics Group, CHIMEI


Other key industry trends

  • In terms of revenue, China accounted for 9.4% of the global biopharma plastics market in 2022.
  • Country-wise, China is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China biopharma plastics market is projected to lead the regional market in terms of revenue in 2030.
  • China is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,134.5 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Biopharma Plastics Market Companies

Name Profile # Employees HQ Website

China biopharma plastics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biopharma plastics market will help companies and investors design strategic landscapes.


Polyvinyl chloride (pvc) was the largest segment with a revenue share of 21.26% in 2024. Horizon Databook has segmented the China biopharma plastics market based on polyethylene (pe), polypropylene (pp), acrylonitrile butadiene styrene (abs), polyethylene terephthalate (pet), polyvinyl chloride (pvc), polytetrafluoroethylene (ptfe), polycarbonate (pc), other covering the revenue growth of each sub-segment from 2019 to 2030.


The biopharma plastics market in China is projected to witness substantial growth over the forecast period. The growth can be attributed to high healthcare costs, increasing private and public expenditure on biopharma industry, and the growing burden of diseases.

Furthermore, the increasing geriatric population is expected to be a major contributor to the healthcare industry, which is expected to positively impact the biopharma plastics market over the forecast period.

Amid the rising cases of the COVID-19 in China, the demand for medical equipment, including medical components, surgical tools, face masks, gloves & aprons, ventilators, and others which are being exported to various countries such as the U.S., the UK, Spain, Italy, and India, can positively impact the biopharma plastics market.

Reasons to subscribe to China biopharma plastics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of China biopharma plastics market databook

  • Our clientele includes a mix of biopharma plastics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the China biopharma plastics market , including forecasts for subscribers. This country databook contains high-level insights into China biopharma plastics market from 2019 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

China biopharma plastics market size, by polymer type, 2019-2030 (US$M)

China Biopharma Plastics Market Outlook Share, 2024 & 2030 (US$M)

China biopharma plastics market size, by polymer type, 2019-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more